Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network, offers lessons learned from practicing value-based care.
Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network, offers lessons learned from practicing value-based care.
Transcript
Having practiced value-based care for several years, what are some of the biggest lessons learned?
The biggest lessons that we’ve learned is really, I think, how phenomenal the impact is on patient care as much anything. I think when we started this 4 years ago, the first shared-savings contract that we had was a Cigna contract, and I think the additional, really, customer service, and exceptional touch we have with our patients has been probably the biggest thing that we’ve learned.
The fact that we can do a lot of training with our patients outside of the clinic has a tremendous impact, I think they understand what they’re going through to a much greater extent. We do a lot more education with nutrition, we assesses, I think, more closely their mental status and just in general have the opportunity to communicate with the patient in a way that is difficult to do when you’re trying to take care of multiple patients at the site level.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More